🧬 Liquid biopsy may be transforming precision oncology—but are healthcare systems keeping up? Article 📰 sciencedirect.com/science/ar… Liquid biopsy in oncology practice: A global survey by the Young Committee of the International Society of Liquid Biopsy (ISLB) done in collaboration with OncoAlert 🚨 A global survey of 393 oncology providers across 59 countries 🌐 reveals that liquid biopsy 🩸 is widely valued but inconsistently implemented. ➡️ While 88% consider it important, use remains limited, with major differences by region, income level, and practice setting. Cost, test availability, interpretation challenges, and turnaround time were key barriers. ✅ Structured workflows and molecular tumor board support also varied substantially, highlighting the need for context-specific strategies to expand equitable implementation. @eleonora_nicolo @SurbhiSinghalMD @ESaldanhaMD @KonVenetis @letipontolillo @ddemiguelperez @AngeloDipa_ @nnadiagee @PasqualePisapia @A_OrtegaFranco @mgoudaMD @DrMirallas @ErulEnes @weoncologists @RobertoBoreaMD @ReduzziCarol @isliquidbiopsy Pinging @ChristianRolfo @UmbertoMalapel1 @matteolambe @DrYukselUrun @tompowles1 @PGrivasMDPhD @scocmem @nataliagandur @to_be_elizabeth @CathyEngMD @BenWestphalen @graokane @christine_lovly @BRicciutiMD @UOzkerim @DrVilmaPBarcia @DraMartinezLago